APA-Zitierstil (7. Ausg.)

Li, H., Liu, J., Lan, S., Zhong, R., Cui, Y., Christopoulos, P., . . . Cheng, Y. (2023). An advanced NSCLC patient with ALK-RNF144A and HIP1-ALK fusions treated with ALK-TKI combination therapy: A case report. Translational Lung Cancer Research, 12(12), . https://doi.org/10.21037/tlcr-23-656

Chicago-Zitierstil (17. Ausg.)

Li, Hui, Jingjing Liu, Shaowei Lan, Rui Zhong, Yanan Cui, Petros Christopoulos, Erin L. Schenk, Takaaki Sasaki, und Ying Cheng. "An Advanced NSCLC Patient with ALK-RNF144A and HIP1-ALK Fusions Treated with ALK-TKI Combination Therapy: A Case Report." Translational Lung Cancer Research 12, no. 12 (2023). https://doi.org/10.21037/tlcr-23-656.

MLA-Zitierstil (9. Ausg.)

Li, Hui, et al. "An Advanced NSCLC Patient with ALK-RNF144A and HIP1-ALK Fusions Treated with ALK-TKI Combination Therapy: A Case Report." Translational Lung Cancer Research, vol. 12, no. 12, 2023, https://doi.org/10.21037/tlcr-23-656.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.